risks of glp-1 medications linked to major drop in pancreatic, colorectal cancer risk https://www.medicalnewstoday.com/articles/weight-loss-drugs-glp-1-slash-risk -4-types-cancer-50-or-more-study pros and cons of glp

2,3 GLP-1 Receptor Agonists: A Critical Look at the Evidence Two GLP-1 receptor agonists, semaglutide and liraglutide (Saxenda), are approved by the US Food and Drug Administration for treating obesity in adolescents 12 years and older with a BMI at the 95th percentile or higher

Vogel J, Cinatl J, Dauletbaev N, et al

How to Evaluate an S-Acetyl Product For S-acetyl glutathione, useful considerations include: Ingredient identity and sourcing Amount of S-acetyl glutathione per serving Purity and stability testing Independent quality controls Capsule excipients and tolerance Whether the claimed benefits remain proportional to the available evidence The presence of an acetyl group provides a reasonable delivery rationale

In Proceedings of the Diabetes Care

Zeleke et al., 2025)